Search

Your search keyword '"Proietti, Carla"' showing total 53 results

Search Constraints

Start Over You searched for: Author "Proietti, Carla" Remove constraint Author: "Proietti, Carla" Database Unpaywall Remove constraint Database: Unpaywall
53 results on '"Proietti, Carla"'

Search Results

2. Data from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies

3. Supplementary Table S2 from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies

4. Supplementary Table S2 from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies

5. Supplementary Methods S1 from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies

6. Supplementary Table S3 from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies

7. Supplementary Methods S1 from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies

8. Supplementary Table S1 from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies

9. Supplementary Table S3 from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies

10. Supplementary Table S1 from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies

11. Data from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies

12. Figure S3 from Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan

13. Tables S2-S4 from Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan

14. Figure S2 from Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan

15. Supplemental Methods from Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan

16. Table S1 from Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan

17. Tables S2-S4 from Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan

18. Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies

19. Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease

22. Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma

23. Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study

24. Identifying Epstein-Barr virus peptide sequences associated with differential IgG antibody response

25. Abstract 833: Characterization of the humoral immune response to the EBV proteome in extranodal natural killer T-cell lymphoma

26. Memory CD8 + T cell compartment associated with delayed onset of Plasmodium falciparum infection and better parasite control in sickle‐cell trait children

27. Correction: Identification of a Novel, EBV-based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan

28. Development and validation of serological markers for detecting recent Plasmodium vivax infection

29. Validation of an Epstein-Barr Virus Antibody Risk Stratification Signature for Nasopharyngeal Carcinoma by Use of Multiplex Serology

31. The Association between the Comprehensive Epstein–Barr Virus Serologic Profile and Endemic Burkitt Lymphoma

33. Evaluation of the antibody response to the EBV proteome in EBV‐associated classical Hodgkin lymphoma

34. Protective Immunity against Severe Malaria in Children Is Associated with a Limited Repertoire of Antibodies to Conserved PfEMP1 Variants

36. Protective Immunity Against Severe Malaria is Associated with a Repertoire of Antibodies to Conserved PfEMP1 Variants

37. Development and validation of serological markers for detecting recent exposure toPlasmodium vivaxinfection

38. Protective immunity against severe malaria is associated with antibodies to a conserved repertoire of PfEMP1 variants

39. Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan

40. Patterns of Interindividual Variability in the Antibody Repertoire Targeting Proteins Across the Epstein-Barr Virus Proteome

41. Antibodies Targeting the Comprehensive Epstein-Barr Virus Proteome and Hodgkin Lymphoma

43. Mining, visualizing and comparing multidimensional biomolecular data using the Genomics Data Miner (GMine) Web-Server

44. Serology describes a profile of declining malaria transmission in Farafenni, The Gambia

48. Serum IgE Reactivity Profiling in an Asthma Affected Cohort

49. Continuing Intense Malaria Transmission in Northern Uganda

50. Plasmodium ovale curtisi and Plasmodium ovale wallikeri circulate simultaneously in African communities

Catalog

Books, media, physical & digital resources